Dr. Zoubeidi awarded PCC-Movember Translation Acceleration Grant

Date Posted: 
2017-07-26

July 26, 2017 - TORONTO, ON - Continuing their longstanding tradition of partnering to fund high quality Canadian prostate cancer research, Prostate Cancer Canada (PCC) and The Movember Foundation today announced two new projects with very real potential to make a tangible difference in the lives of men living with aggressive forms of prostate cancer.

Dr. Amina Zoubeidi is one of the recipients, for a project to develop blockers of BRN2, a gene linked to the growth of aggressive neuroendocrine prostate cancer.  She will receive $1.5 million over a 3 year period, towards objective of accelerating the transition of existing knowledge into clinical application.

Targeting a protein that assists a deadly form of prostate cancer

Principal Investigator: Dr. Amina Zoubeidi, Vancouver Prostate Centre, Vancouver Coastal Health Research Institute

Dr. Zoubeidi and her team are focusing on a deadly form of prostate cancer called neuroendocrine prostate cancer (NEPC), for which the only treatment option is a highly toxic chemotherapy and survival is measured in months. Building upon the discovery of a protein that is essential for the growth and survival of NEPC, the team is developing first-in-field blockers of this protein. At the successful completion of this research, they will have fine-tuned an ideal drug that is ready for immediate application in a clinical trial, with the ultimate goal of changing the way NEPC is treated.

Read the Prostate Cancer Canada press release here.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

PCF BC

Ride to Live 2018 and 50-50 Draw: May 27

The West Coast Motorcycle Ride to Live, raising funds for Prostate Cancer Foundation BC, takes place on Sunday May 27, 2018 in Vancouver, Victoria & the Fraser Valley. Follow the links to join a ride or donate to a rider; or to buy a ticket for a 50/50 draw (BC residents only).

Employment

Work at the Vancouver Prostate Centre

Thursday, January 18, 2018

Discovery of a promising new medication to block "master key" of cancer growth

Dr. Chris Ong
Tuesday, February 20, 2018

Drs. Wyatt and Chi: ctDNA predicts resistance to AR-targeted therapy

VCHRI News article on study of ctDNA predicting resistance to AR-targeted therapy
DNA

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.